DK299087D0 - PROTEINS AND DERIVATIVES THEREOF - Google Patents

PROTEINS AND DERIVATIVES THEREOF

Info

Publication number
DK299087D0
DK299087D0 DK299087A DK299087A DK299087D0 DK 299087 D0 DK299087 D0 DK 299087D0 DK 299087 A DK299087 A DK 299087A DK 299087 A DK299087 A DK 299087A DK 299087 D0 DK299087 D0 DK 299087D0
Authority
DK
Denmark
Prior art keywords
proteins
derivatives
Prior art date
Application number
DK299087A
Other languages
Danish (da)
Inventor
Bjoern Andersen Nexoe
Esper Boel
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK299087A priority Critical patent/DK299087D0/en
Publication of DK299087D0 publication Critical patent/DK299087D0/en
Priority to JP63505229A priority patent/JPH03503757A/en
Priority to PCT/DK1988/000089 priority patent/WO1988009811A1/en
Priority to EP88905725A priority patent/EP0365568A1/en
Priority to DK627389A priority patent/DK162169C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/7455Thrombomodulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK299087A 1987-06-12 1987-06-12 PROTEINS AND DERIVATIVES THEREOF DK299087D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DK299087A DK299087D0 (en) 1987-06-12 1987-06-12 PROTEINS AND DERIVATIVES THEREOF
JP63505229A JPH03503757A (en) 1987-06-12 1988-06-09 Proteins and their derivatives
PCT/DK1988/000089 WO1988009811A1 (en) 1987-06-12 1988-06-09 Proteins and derivatives thereof
EP88905725A EP0365568A1 (en) 1987-06-12 1988-06-09 Proteins and derivatives thereof
DK627389A DK162169C (en) 1987-06-12 1989-12-12 RECOMBINATE PROTEINS WITH THROMBOMODULIN ACTIVITY, DNA CONSTRUCTIONS CODING THEREOF, VECTORS, CELLS AND PROCEDURES FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THE PROTEINES AND THE PROTEINES CONTAINING THE PROTEINES AND THE PROTEINES CONTAINING THE PROTEINES AND THE PROTEINES CONTAINING THE PROTEINS, AND THE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK299087A DK299087D0 (en) 1987-06-12 1987-06-12 PROTEINS AND DERIVATIVES THEREOF

Publications (1)

Publication Number Publication Date
DK299087D0 true DK299087D0 (en) 1987-06-12

Family

ID=8117912

Family Applications (1)

Application Number Title Priority Date Filing Date
DK299087A DK299087D0 (en) 1987-06-12 1987-06-12 PROTEINS AND DERIVATIVES THEREOF

Country Status (4)

Country Link
EP (1) EP0365568A1 (en)
JP (1) JPH03503757A (en)
DK (1) DK299087D0 (en)
WO (1) WO1988009811A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2766473B2 (en) * 1987-01-08 1998-06-18 旭化成工業株式会社 Peptide promoting the activation of protein C by thrombin
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
WO1990010081A1 (en) * 1989-02-17 1990-09-07 Codon Soluble analogs of thrombomodulin
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US6239101B1 (en) 1989-07-05 2001-05-29 Oklahoma Medical Research Foundation Thrombin binding polypeptides
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
CA2065409C (en) * 1990-06-27 2002-05-14 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
KR930008093B1 (en) * 1990-08-03 1993-08-25 아사히가세이고오교 가부시끼가이샤 New polypeptide and its composition
CA2648350A1 (en) * 1990-08-15 1992-03-05 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
ES2220905T3 (en) * 1992-02-05 2004-12-16 Paion Gmbh PROTEASE RESISTANT THROMBOMODULIN ANALOG.
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
NZ296648A (en) * 1994-10-18 2001-05-25 Corvas Int Inc Nematode-extracted serine protease inhibitors and anticoagulant proteins
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
CA2202351A1 (en) * 1994-10-18 1996-04-25 George Phillip Vlasuk Nematode-extracted serine protease inhibitors and anticoagulant proteins
JPH11299487A (en) * 1996-04-03 1999-11-02 Asahi Chem Ind Co Ltd New gene
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
KR101013697B1 (en) 2002-05-01 2011-02-10 바이엘 쉐링 파마 악티엔게젤샤프트 Novel Tissue Factor Targeted Thrombomodulin Fusion Proteins as Anticoagulants
MX2009003384A (en) 2006-10-06 2009-04-08 Asahi Kasei Pharma Corp Therapeutic and/or ameliorating agent for disseminated intravascular coagulation.
WO2008117735A1 (en) 2007-03-23 2008-10-02 Asahi Kasei Pharma Corporation Method for producing soluble thrombomodulin of high purity
US20120165244A1 (en) * 2008-10-30 2012-06-28 Hua-Lin Wu Methods for binding lewis y antigen
JP5722314B2 (en) 2010-04-30 2015-05-20 旭化成ファーマ株式会社 High purity soluble thrombomodulin and method for producing the same
CA2807749C (en) * 2010-08-05 2023-02-28 Council Of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties
HUE050698T2 (en) 2011-11-15 2020-12-28 Asahi Kasei Pharma Corp Medicine for treatment and/or improvement of sepsis
ES2743767T3 (en) 2012-05-31 2020-02-20 Univ Kinki Agent to prevent and / or treat peripheral neuropathic pain caused by an anticancer drug
WO2020067389A1 (en) 2018-09-28 2020-04-02 旭化成ファーマ株式会社 Medication for alleviating symptoms of peripheral neuropathy caused by anticancer drug and/or suppressing onset of peripheral neuropathy
AU2019366008B2 (en) 2018-10-22 2023-12-14 Asahi Kasei Pharma Corporation Drug for treating and/or improving septicemia associated with coagulation abnormality

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000050A1 (en) * 1985-06-28 1987-01-15 Asahi Kasei Kogyo Kabushiki Kaisha Novel physiologically active substance having blood coagulation controlling activity

Also Published As

Publication number Publication date
EP0365568A1 (en) 1990-05-02
WO1988009811A1 (en) 1988-12-15
JPH03503757A (en) 1991-08-22

Similar Documents

Publication Publication Date Title
DK299087D0 (en) PROTEINS AND DERIVATIVES THEREOF
DK540289A (en) PROTEIN
DK22588D0 (en) PEPTIDE DERIVATIVES
MC2034A1 (en) PREPARATIONS
DK275788D0 (en) PROTEIN
DK254488A (en) AZAINDOL AND INDOLIZIN DERIVATIVES
DK183488D0 (en) FOREIGN DERIVATIVES AND USE THEREOF
DK507188D0 (en) CHOLECALCIFERAL DERIVATIVES
DK378088A (en) ALKENDER DERIVATIVES
DK49688A (en) PROPIOLOPHENONE DERIVATIVES
DK395288D0 (en) PROTEINS
DK84489D0 (en) PREPARATIONS
DK4390A (en) PEPTIDE DERIVATIVES
DK345087D0 (en) PROTEIN
DK271088D0 (en) TIENOPYRIDINE DERIVATIVES
DK354989A (en) MODIFIED PROTEINS
DK695788D0 (en) NAPHTALEN DERIVATIVES
DK679488D0 (en) PEPTIDE DERIVATIVES
DK71488D0 (en) DIPENYLETHYLEN DERIVATIVES
DK627389D0 (en) PROTEINS AND DERIVATIVES THEREOF
DK619589D0 (en) SPHINGENIN AND DERIVATIVES THEREOF
DK179288A (en) DIOXOLAN AND DIOXANDER DERIVATIVES
DK313789A (en) THIADIAZINON DERIVATIVES
DK428987D0 (en) AND FALLLESS
DK408389D0 (en) NOVEL PROTEIN DERIVATIVES

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment